Reply: adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature.
作者信息
Ricceri F, Pescitelli L, Lazzeri L, Di Cesare A, Prignano F
机构信息
Dermatology Unit, Department of Surgery and Translational Medicine, University of Florence, 50125, Florence, Italy.
出版信息
J Eur Acad Dermatol Venereol. 2017 Nov;31(11):e486. doi: 10.1111/jdv.14300. Epub 2017 May 15.
PMID:28449189
Abstract
摘要
Zotero 插件